Compliance with antiplatelet therapy in patients with ischemic cerebrovascular disease. Assessment by platelet aggregation testing. | Zendy

TAKEYA KOMIYA | Zendy; Masatoshi Kudo | Zendy; Takao Urabe | Zendy; Yasuhiro Mizuno | Zendy

Open Access

Compliance with antiplatelet therapy in patients with ischemic cerebrovascular disease. Assessment by platelet aggregation testing.

Author(s) -

TAKEYA KOMIYA,

Masatoshi Kudo,

Takao Urabe,

Yasuhiro Mizuno

Publication year - 1994

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/01.str.25.12.2337

Subject(s) - medicine , aspirin , ticlopidine , platelet , compliance (psychology) , platelet aggregation , antiplatelet drug , platelet aggregation inhibitor , anesthesia , pharmacology , clopidogrel , psychology , social psychology

Antiplatelet therapy is currently one of the methods for preventing transient ischemic attacks and cerebral thrombosis. Because antiplatelet agents are generally administered on a long-term basis, patient compliance is an important factor. The purpose of this study was to determine the compliance of patients during antiplatelet therapy by testing platelet aggregation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research